What Is Testosterone (Total, Male)? Normal vs Optimal Range Explained

The lab reference range of 264–916 ng/dL was established using population data that includes men from age 19 to 90+, creating a range so wide it loses clinical meaning for any individual. A 30-year-old man with total testosterone at 300 ng/dL falls within this range but sits in the bottom quartile for his age—and almost certainly experiences symptoms. The CTD catalogs over 1,900 chemical interactions affecting androgen receptor and steroidogenic gene pathways, from medications to environmental endocrine disruptors, illustrating the breadth of factors that influence testosterone levels. Symptoms of low testosterone—fatigue, reduced libido, difficulty building muscle, depressed mood—commonly surface below 400 ng/dL, yet men in the 300–400 range are routinely told their levels are normal. The optimal range of 500–800 ng/dL reflects the zone where energy, sexual function, body composition, and cognitive performance align, based on symptom-resolution data rather than statistical population distributions.

Testosterone production follows a steep age-related decline that begins around age 30, dropping approximately 1 to 2 percent per year. PubMed indexes over 35,000 publications on male testosterone, with consistent evidence that this decline accelerates with obesity, insulin resistance, chronic stress, poor sleep, and certain medications. Visceral fat is particularly problematic because it contains high concentrations of aromatase, the enzyme that converts testosterone to estradiol. A man carrying 30 or more pounds of excess abdominal fat can lose 100 to 200 ng/dL of total testosterone through this conversion alone. The result is a vicious cycle: low testosterone promotes fat storage, and fat tissue converts more testosterone to estrogen, further lowering levels. Breaking this cycle through body composition changes, sleep optimization, and addressing insulin resistance can raise total testosterone by 100 to 200 ng/dL without pharmaceutical intervention.

Total testosterone alone tells only part of the story because 97 to 99 percent of circulating testosterone is bound to proteins—primarily SHBG and albumin. FAERS documents over 6,500 adverse event reports related to testosterone replacement therapy, many involving men who were started on treatment based on a low total testosterone without checking free testosterone and SHBG first. An obese man with total testosterone of 280 ng/dL but low SHBG may actually have adequate free testosterone, meaning his symptoms are more likely driven by metabolic dysfunction than true hypogonadism. Conversely, a lean man with total testosterone of 480 ng/dL and high SHBG may have critically low free testosterone. The complete assessment requires total testosterone, free testosterone, and SHBG measured together on an early morning fasting blood draw.